Latest News

See all news >
  • 18 December 2014

    CJEU decides parthenotes are not stem cells

    In a decision handed down today, the Court of Justice of the European Union (CJEU) has decided that unfertilised human egg cells stimulated to divide in a manner analogous to that of a human embryo are not excluded from patentability within the European Union under the Directive on the Legal Protection of Biotechnological Inventions (Directive 98/44/EC, known as the “Biotech Directive”).  This new decision has consequences for European Patents and applications at the EPO, and for national patents and applications in EU member states.

    Click here for more information.

  • 16 December 2014

    European Biotechnological and Pharmaceutical Patenting Webcast – 19 December 2014

    Mewburn Ellis Patent Attorney Joseph Lenthall will speak at the webcast entitled “European Biotechnological and Pharmaceutical Patenting” on Friday 19 December 2014. The webcast provides a review of recent changes in UK and European patent law, with particular focus on aspects that are most relevant to the Biotechnology and Pharmaceutical industries. Details of the webcast can be found here.

    Click here for more information.

  • 11 December 2014

    Malta Ratifies UPC Agreement

    Malta has become the sixth country to ratify the Unified Patent Court (UPC) Agreement, joining Austria, Belgium, Denmark, France and Sweden.  Seven more countries, including the UK and Germany, are required to ratify the UPC Agreement before the Agreement enters into force.

    Click here for more information.

Our People

Our People

View all >

or search for an individual...

FAQ

FAQ

See answers to commonly asked questions

Patents > Trade Marks > Designs > General >
Focus on Innovation

Focus on Innovation

Innovation: the creation of new and exciting products, services and solutions.  A key part of every successful  business.

Find out more...

UPCOMING EVENTS

UPCOMING EVENTS